[HTML][HTML] Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is
still raging. However, the pathophysiology of acute and post-acute manifestations of COVID …
still raging. However, the pathophysiology of acute and post-acute manifestations of COVID …
[HTML][HTML] Diabetes and the COVID-19 pandemic
Almost immediately after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) virus emerged, it was evident that people with chronic diseases, including diabetes, were …
2) virus emerged, it was evident that people with chronic diseases, including diabetes, were …
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …
19. We compared the effects of the preadmission use of antidiabetic medications on the in …
[HTML][HTML] Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression
MI Maiorino, M Longo, L Scappaticcio… - Cardiovascular …, 2021 - Springer
Background Besides providing reassurance about cardiovascular (CV) safety of newer
diabetes drugs, cardiovascular outcome trials (CVOTs) have also shown encouraging …
diabetes drugs, cardiovascular outcome trials (CVOTs) have also shown encouraging …
[HTML][HTML] The association between antidiabetic agents and clinical outcomes of COVID-19 patients with diabetes: a Bayesian network meta-analysis
Y Chen, X Lv, S Lin, M Arshad, M Dai - Frontiers in Endocrinology, 2022 - frontiersin.org
Aims This study aimed to assess the impact of different antidiabetic agents on individuals
with diabetes and COVID-19. Methods We searched PubMed, Web of Science, Embase …
with diabetes and COVID-19. Methods We searched PubMed, Web of Science, Embase …
Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review …
Aims This study aims to examine the effectiveness of using sodium glucose transporter-2
inhibitor (SGLT-2i) before hospital admission on Covid-19 outcomes in diabetic patients …
inhibitor (SGLT-2i) before hospital admission on Covid-19 outcomes in diabetic patients …
Analysis of all-cause hospitalization and death among nonhospitalized patients with type 2 diabetes and SARS-CoV-2 infection treated with molnupiravir or …
Importance Diabetes and COVID-19 are both global pandemics, and type 2 diabetes is a
common comorbidity in patients with acute COVID-19 and is proven to be a key determinant …
common comorbidity in patients with acute COVID-19 and is proven to be a key determinant …
[HTML][HTML] Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in …
MV Shestakova, OK Vikulova, AR Elfimova… - Frontiers in …, 2022 - frontiersin.org
The aim To study the association of demographic, clinical, and laboratory factors and the
use of glucose-lowering drugs and anti-coronavirus disease (COVID-19) vaccination with …
use of glucose-lowering drugs and anti-coronavirus disease (COVID-19) vaccination with …
[HTML][HTML] Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with …
J Du, J Fu, W Zhang, L Zhang… - International …, 2023 - spandidos-publications.com
The worldwide COVID‑19 pandemic was brought on by a new coronavirus (SARS Cov‑2). A
marker/receptor called Dipeptidyl peptidase 4/CD26 (DPP4/CD26) may be crucial in …
marker/receptor called Dipeptidyl peptidase 4/CD26 (DPP4/CD26) may be crucial in …
Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID‐19 patients with diabetes: a population‐based study in Lombardy
L Ojeda‐Fernández, A Foresta… - Diabetes, Obesity …, 2022 - Wiley Online Library
Aim To compare the association of metformin use and coronavirus disease 2019 (COVID‐
19) outcomes in a cohort of 31 966 patients with diabetes in Lombardy. Methods We used a …
19) outcomes in a cohort of 31 966 patients with diabetes in Lombardy. Methods We used a …